Table 1 Patient demographics and clinical characteristics
Patient | Age (years) | Sex | Race | MH | Medications | Vaccine | Episodes of gross hematuria before vaccination | Baseline (hematuria/uPCR/sCr) | Timing of gross hematuria after vaccination | Associated symptoms | Presentation after second dose (hematuria/uPCR/sCr) | Follow-up after second dose (hematuria/uPCR/sCr) | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 38 | F | W | IgAN | RAASi | Moderna | Yes | (positive/0.63/well-preserved kidney function) | D1 after the second dose | Fever at D1 | NA | (NA/1.40/well-preserved kidney function) 3 weeks after | 4 |
2 | 38 | F | W | IgAN | CY + Pred, then RAASi | Moderna | No | (positive/0.63/well-preserved kidney function) | D1 after second dose | Fever at D1 | NA | (NA/0.40/well-preserved kidney function) 3 weeks after | 4 |
3 | 52 | F | A | IgAN | RAASi | Pfizer | Yes | (NA/0.6331/0.7–0.8) | D1 after second dose | Fever | (positive/2.4113/NA) | (resolved/1.441/NA) 5 days after | 5 |
4 | 41 | F | C | DM | NA | Pfizer | No | (NA/neg/NA) | D2 after second dose | Generalized myalgia at D2 | (> 200/1.73/2.03) | 6 | |
5 | 30 | M | WE/SA | None | None | Moderna | No | NA | D2 after second dose | Fever at D2 | (3+/4+/1.02) | (positive/0.08/NA) 2 weeks after | 7 |
6 | NA | NA | NA | IgAN | NA | Pfizer | Yes | (NA/1.56/0.8) | D6 after second dose | Myalgia at D6 | (positive/3.0/3.53) | (NA/baseline/baseline) 2 months after | 11 |
7 | NA | NA | NA | IgAN | NA | Pfizer | No | (NA/0.61/1.0) | D1 after second dose | Body aches | (positive/0.92/1.16) | (resolved/NA/NA) 5 days after | 11 |
8 | 41 | F | NA | IgAN | Tac, MPA, and steroids for KT | Pfizer | NA | (NA/0/NA) | D1 after first dose | Marked leukocytosis | NA | (NA/0.41/GFR 57 ml/min/1.73 m2) | 12 |
9 | 50 | M | NA | IgAN, HTN | None | Pfizer | NA | (11–25/2.40/1/17) | D2 after second dose | NA | (> 50/3.56/1.54) | (11–25/2.20/1.24) | 13 |
Our case | 21 | F | Japanese | None | None | Pfizer | No | (3+/negative/0.60) | D2 after second dose | Fever at D2 | (> 100/0.15/0.57) | (10–19/0.09/0.56) 6 weeks after |